FIELD: chemistry.
SUBSTANCE: invention relates to new indolylmaleimide derivatives of formula I: , where: Ra is H, C1-4alkyl; one of Ra, Rc, Rd and Re is C1-4alkyl; and the other three substitutes are H; or Rb, Rd, Re are all H; and R is a radical of formula (a): , where R1 is -(CH2)n-NR3R4, where each of R3 and R4 are independently H, C1-4alkyl; n is 0, 1, 2; R2 is H; halogen; or its pharmaceutically acceptable salt.
EFFECT: wider field of use of the compounds.
8 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
INDOLYLMALEIMIDE DERIVATIVES, METHOD OF THEIR OBTAINING, THEIR APPLICATION AND PHARMACEUICAL COMPOSITION FOR TREATMENT OR PREVENTION OF T-LYMPHOCYTE AND/OR "ПКС"- MEDIATED DISORDERS OR DISEASES | 2003 |
|
RU2340610C2 |
DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
MACROHETEROCYCLIC COMPOUNDS | 2001 |
|
RU2275373C2 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2794333C1 |
DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS SUITABLE AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES | 2018 |
|
RU2804468C2 |
3-ARYL-5-SUBSTITUTED ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC APPLICATION | 2013 |
|
RU2696572C2 |
BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
IMIDAZOPYRIDINE COMPOUNDS AS PAD INHIBITORS | 2018 |
|
RU2782743C2 |
MACROCYCLIC PEPTIDES ELICITING ACTIVITY WITH RESPECT TO HEPATITIS C VIRUS | 2000 |
|
RU2247126C2 |
SYMMETRIC AND ASYMMETRIC DERIVATIVES OF DIPHENYLUREA (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITION OF RAF KINASE- MEDIATED TUMOR CELLS PROLIFERATION | 1998 |
|
RU2247109C9 |
Authors
Dates
2009-11-20—Published
2005-01-19—Filed